Oudard S - Search Results

1

Management of painful pelvic bone metastasis of renal cell carcinoma using embolization, radio-frequency ablation, and cementoplasty: a prospective evaluation of efficacy and safety.

Pellerin O, Medioni J, Vulser C, Déan C, Oudard S, Sapoval M. Pellerin O, et al. Among authors: oudard s. Cardiovasc Intervent Radiol. 2014 Jun;37(3):730-6. doi: 10.1007/s00270-013-0740-x. Epub 2013 Oct 4. Cardiovasc Intervent Radiol. 2014. PMID: 24091753

2

[Prostate cancer: update].

Oudard S, Medioni J, Scotté F, Banu E. Oudard S, et al. Bull Cancer. 2005 Oct;92(10):865-73. Bull Cancer. 2005. PMID: 16266870 Free article. Review. French.

3

[Nausea and vomiting in cancer patients].

Lévy E, Scotté F, Médioni J, Oudard S. Lévy E, et al. Among authors: oudard s. Rev Prat. 2006 Nov 30;56(18):2015-9. Rev Prat. 2006. PMID: 17274504 Review. French.

4

Prospective multicenter phase II study of gemcitabine plus platinum salt for metastatic collecting duct carcinoma: results of a GETUG (Groupe d'Etudes des Tumeurs Uro-Génitales) study.

Oudard S, Banu E, Vieillefond A, Fournier L, Priou F, Medioni J, Banu A, Duclos B, Rolland F, Escudier B, Arakelyan N, Culine S; GETUG (Groupe d'Etudes des Tumeurs Uro-Génitales). Oudard S, et al. J Urol. 2007 May;177(5):1698-702. doi: 10.1016/j.juro.2007.01.063. J Urol. 2007. PMID: 17437788 Clinical Trial.

5

Complete cerebral response with sunitinib for metastatic renal cell carcinoma.

Medioni J, Cojocarasu O, Belcaceres JL, Halimi P, Oudard S. Medioni J, et al. Among authors: oudard s. Ann Oncol. 2007 Jul;18(7):1282-3. doi: 10.1093/annonc/mdm275. Ann Oncol. 2007. PMID: 17675397 Free article. No abstract available.

6

Serum PSA half-life as a predictor of survival for hormone-refractory prostate cancer patients: modelization using a standardized set of response criteria.

Banu E, Banu A, Medioni J, Levy E, Thiounn N, Mejean A, Andrieu JM, Oudard S. Banu E, et al. Among authors: oudard s. Prostate. 2007 Oct 1;67(14):1543-9. doi: 10.1002/pros.20627. Prostate. 2007. PMID: 17705243

7

Treatment options in renal cell carcinoma: past, present and future.

Oudard S, George D, Medioni J, Motzer R. Oudard S, et al. Ann Oncol. 2007 Sep;18 Suppl 10:x25-31. doi: 10.1093/annonc/mdm411. Ann Oncol. 2007. PMID: 17761720 Free article. Review.

8

[New targeted therapies in hormone-refractory prostate cancer].

Oudard S, Banu E, Scotte F, Beuzeboc P, Guyader C, Medioni J. Oudard S, et al. Bull Cancer. 2007 Jul;94(7 Suppl):F62-8. Bull Cancer. 2007. PMID: 17845995 Review. French.

9

Prostate-specific antigen doubling time before onset of chemotherapy as a predictor of survival for hormone-refractory prostate cancer patients.

Oudard S, Banu E, Scotte F, Banu A, Medioni J, Beuzeboc P, Joly F, Ferrero JM, Goldwasser F, Andrieu JM. Oudard S, et al. Ann Oncol. 2007 Nov;18(11):1828-33. doi: 10.1093/annonc/mdm332. Epub 2007 Sep 9. Ann Oncol. 2007. PMID: 17846024 Free article.

10

[Chemotherapy for prostate cancer].

Medioni J, Dionysopoulos D, Banu E, Scotté F, Beuzeboc P, Oudard S. Medioni J, et al. Among authors: oudard s. Presse Med. 2008 May;37(5 Pt 2):814-20. doi: 10.1016/j.lpm.2007.07.019. Epub 2007 Dec 21. Presse Med. 2008. PMID: 18160251 Review. French.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

443 results

Search Page

Filters